Asset Details
Do you wish to reserve the book?
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels
Do you wish to request the book?
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels
2017
Overview
Systemic inflammation, which can be induced by metabolic endotoxemia, and corresponding high-fat diet-mediated metabolic disorders are associated with gut microbiota. In the present study reverse transcription-polymerase chain reaction, immunofluorescence, pyrosequencing, ELISA and Oil Red O staining were performed to assess whether berberine can protect against diet-induced obesity, through modulating the gut microbiota and consequently improving metabolic endotoxemia and gastrointestinal hormone levels. Alterations in the gut microbiota induced by berberine resulted in a significant reduction in bacterial lipopolysaccharide levels in portal plasma. Levels of inflammatory and oxidative stress markers, as well as the mRNA expression levels of macrophage infiltration markers in visceral adipose tissue, were also reduced by berberine. Inhibition of the inflammatory response was associated with a reduction in intestinal permeability and an increase in the expression of tight junction proteins. In addition, berberine was reported to restore aberrant levels of gut hormones in the portal plasma, such as glucagon-like peptide-1 and −2, peptide YY, glucose-dependent insulinotropic polypeptide and pancreatic polypeptide. The present findings indicated that berberine, through modulating gut microbiota, restored the gut barrier, reduced metabolic endotoxemia and systemic inflammation, and improved gut peptide levels in high-fat diet-fed rats. The present study suggests that berberine may be an effective therapeutic strategy for the treatment of obesity and insulin resistance.
Publisher
D.A. Spandidos,Spandidos Publications UK Ltd
Subject
/ Animals
/ Dietary Fats - adverse effects
/ Endotoxemia - chemically induced
/ Endotoxemia - prevention & control
/ Enzyme-linked immunosorbent assay
/ Glucagon
/ Glucagon-Like Peptide 1 - blood
/ Glucagon-Like Peptide 2 - blood
/ Insulin
/ Kinases
/ Male
/ Obesity
/ Obesity - chemically induced
/ Obesity - prevention & control
/ Rats
/ Rodents
/ Studies
